
### [NCIT:C7355](http://purl.obolibrary.org/obo/NCIT_C7355)
**Label:** Renal Pelvis Urothelial Carcinoma

**Subclasses:** [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C6148](http://purl.obolibrary.org/obo/NCIT_C6148) (Renal Pelvis Papillary Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C6186](http://purl.obolibrary.org/obo/NCIT_C6186) (Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant), 

**Class expressions from DL-Learner:**

- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CL:1001428](http://purl.obolibrary.org/obo/CL_1001428) (bladder urothelial cell))) 54.35%
- Thing 53.84%
- [NCIT:C54557](http://purl.obolibrary.org/obo/NCIT_C54557) (Renal Pelvis Urothelial Cell) 52.17%
- [NCIT:C12866](http://purl.obolibrary.org/obo/NCIT_C12866) (Transitional Cell) 52.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 52.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) 45.17%
- [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40127](http://purl.obolibrary.org/obo/NCIT_C40127) (Fallopian Tube Leiomyoma))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40122](http://purl.obolibrary.org/obo/NCIT_C40122) (Pelvic Pain))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40116](http://purl.obolibrary.org/obo/NCIT_C40116) (Fallopian Tube Metaplastic Papillary Tumor))) 45.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 45.17%


